ReviewVascular specialist international2025
Endovascular Recanalization for Infrapopliteal Artery Disease in Chronic Limb-Threatening Ischemia: A Practical Review.
Review in Vascular specialist international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lesion Morphology and Technical Success in Diabetic vs. Non-Diabetic Patients with Chronic Limb-Threatening Ischemia Undergoing Endovascular Treatment: A Retrospective Single-Center Study.Medicina (Kaunas, Lithuania) · 2026Article
- From Angiosome to Woundosome: An Interdisciplinary Approach to Personalized Revascularization in Chronic Limb-Threatening Ischemia.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with chronic limb-threatening ischemia (CLTI) are typically older adults with multiple comorbidities, placing them at high risk for major amputation and mortality. As CLTI frequently occurs in patients with diabetes or end-stage renal disease, it often presents as stenosis or occlusion with calcification of the infrapopliteal (IP) arteries. Endovascular therapy (EVT) has become widely adopted as a first-line treatment and an alternative to surgical bypass in the management of CLTI, owing to its high technical success rate and favorable limb salvage rate. However, IP lesions in patients with CLTI are often long, diffuse, heavily calcified, and totally occluded and may extend below the ankle, making it challenging to achieve optimal procedural success and long-term durability. This review aimed to explore current treatment strategies for CLTI associated with IP artery disease and discuss practical techniques for achieving successful EVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.